The authors discuss the interplay between distinct cell death signaling cascades and disease pathogenesis and describe pharmacological agents targeting key players in the cell death signaling pathways that have progressed through to clinical trials.
[Cell Death & Differentiation]
7753456 {7753456:C7592H6R} apa 50 1 163241 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-7b8b2fd33eb12c28b5783fe31a23d1f7%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22C7592H6R%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moujalled%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMoujalled%2C%20D.%2C%20Strasser%2C%20A.%2C%20%26amp%3B%20Liddell%2C%20J.%20R.%20%282021%29.%20Molecular%20mechanisms%20of%20cell%20death%20in%20neurological%20diseases.%20%3Ci%3ECell%20Death%20%26amp%3B%20Differentiation%3C%5C%2Fi%3E%2C%201%26%23x2013%3B16.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41418-021-00814-y%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41418-021-00814-y%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DC7592H6R%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20mechanisms%20of%20cell%20death%20in%20neurological%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diane%22%2C%22lastName%22%3A%22Moujalled%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Strasser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20R.%22%2C%22lastName%22%3A%22Liddell%22%7D%5D%2C%22abstractNote%22%3A%22Tightly%20orchestrated%20programmed%20cell%20death%20%28PCD%29%20signalling%20events%20occur%20during%20normal%20neuronal%20development%20in%20a%20spatially%20and%20temporally%20restricted%20manner%20to%20establish%20the%20neural%20architecture%20and%20shaping%20the%20CNS.%20Abnormalities%20in%20PCD%20signalling%20cascades%2C%20such%20as%20apoptosis%2C%20necroptosis%2C%20pyroptosis%2C%20ferroptosis%2C%20and%20cell%20death%20associated%20with%20autophagy%20as%20well%20as%20in%20unprogrammed%20necrosis%20can%20be%20observed%20in%20the%20pathogenesis%20of%20various%20neurological%20diseases.%20These%20cell%20deaths%20can%20be%20activated%20in%20response%20to%20various%20forms%20of%20cellular%20stress%20%28exerted%20by%20intracellular%20or%20extracellular%20stimuli%29%20and%20inflammatory%20processes.%20Aberrant%20activation%20of%20PCD%20pathways%20is%20a%20common%20feature%20in%20neurodegenerative%20diseases%2C%20such%20as%20amyotrophic%20lateral%20sclerosis%20%28ALS%29%2C%20Alzheimer%5Cu2019s%20disease%2C%20Parkinson%5Cu2019s%20disease%2C%20and%20Huntington%5Cu2019s%20disease%2C%20resulting%20in%20unwanted%20loss%20of%20neuronal%20cells%20and%20function.%20Conversely%2C%20inactivation%20of%20PCD%20is%20thought%20to%20contribute%20to%20the%20development%20of%20brain%20cancers%20and%20to%20impact%20their%20response%20to%20therapy.%20For%20many%20neurodegenerative%20diseases%20and%20brain%20cancers%20current%20treatment%20strategies%20have%20only%20modest%20effect%2C%20engendering%20the%20need%20for%20investigations%20into%20the%20origins%20of%20these%20diseases.%20With%20many%20diseases%20of%20the%20brain%20displaying%20aberrations%20in%20PCD%20pathways%2C%20it%20appears%20that%20agents%20that%20can%20either%20inhibit%20or%20induce%20PCD%20may%20be%20critical%20components%20of%20future%20therapeutic%20strategies.%20The%20development%20of%20such%20therapies%20will%20have%20to%20be%20guided%20by%20preclinical%20studies%20in%20animal%20models%20that%20faithfully%20mimic%20the%20human%20disease.%20In%20this%20review%2C%20we%20briefly%20describe%20PCD%20and%20unprogrammed%20cell%20death%20processes%20and%20the%20roles%20they%20play%20in%20contributing%20to%20neurodegenerative%20diseases%20or%20tumorigenesis%20in%20the%20brain.%20We%20also%20discuss%20the%20interplay%20between%20distinct%20cell%20death%20signalling%20cascades%20and%20disease%20pathogenesis%20and%20describe%20pharmacological%20agents%20targeting%20key%20players%20in%20the%20cell%20death%20signalling%20pathways%20that%20have%20progressed%20through%20to%20clinical%20trials.%22%2C%22date%22%3A%222021-06-07%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41418-021-00814-y%22%2C%22ISSN%22%3A%221476-5403%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41418-021-00814-y%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%22TUURQW3H%22%5D%2C%22dateModified%22%3A%222021-06-08T19%3A15%3A54Z%22%7D%7D%5D%7D
Moujalled, D., Strasser, A., & Liddell, J. R. (2021). Molecular mechanisms of cell death in neurological diseases. Cell Death & Differentiation, 1–16. https://doi.org/10.1038/s41418-021-00814-y Cite